Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stents-Reference-Cited by-同舟云学术

Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stents

Published:2011-01 Issue:1 Volume:22 Page:12-17
ISSN:0954-6928
Container-title:Coronary Artery Disease
language:en
Short-container-title:

Author:

Park Hun-Jun,Seo Suk Min,Shin Woo Seung,Kim Hee-Yeol,Choi Yoon Seok,Koh Yoon Seok,Youn Sung-Gyu,Park Mahn Won,Chang Kiyuk,Kim Pum Joon,Jung Hae-Ok,Baek Sang Hong,Chung Wook Sung,Seung Ki-Bae,Yoo Ki-Dong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference35 articles.

1. Diabetes mellitus and clinical and angiographic outcome after coronary stent placement.;Elezi;J Am Coll Cardiol,1998

2. Predictors of clinical outcomes following NIR stent implantation for coronary artery disease: analysis of the results of the First International New Intravascular Rigid-Flex Endovascular Stent Study (FINESS trial).;Feld;J Interv Cardiol,2002

3. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.;Kirtane;J Am Coll Cardiol,2008

4. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.;Sabate;Circulation,2005

5. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.;Iijima;Am Heart J,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of sRAGE in cardiovascular diseases;Advances in Clinical Chemistry;2023

2. Diabetes and restenosis;Cardiovascular Diabetology;2022-02-14

3. Risk factors of in-stent restenosis in patients with diabetes mellitus after percutaneous coronary intervention;Medicine;2021-04-16

4. Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models;Frontiers in Cardiovascular Medicine;2020-03-10

5. Monocyte to HDL ratio in prediction of BMS restenosis in subjects with stable and unstable angina pectoris;Biomarkers in Medicine;2016-08